Usefulness of Platelet-Rich Plasma in the Treatment of Musculoskeletal Disorders
Keywords:
platelet-rich plasma, musculoskeletal disordersAbstract
ABSTRACT
Introduction: Musculoskeletal disorders are common conditions affecting the joints, muscles, nerves, ligaments, and tendons. Platelet-rich plasma (PRP) is an increasingly accepted therapeutic preparation due to its theoretical potential to repair tissues with low healing capacity and its safety.
Objective: To evaluate PRP in the treatment of musculoskeletal disorders of the upper limbs.
Methods: An observational, longitudinal, prospective study was conducted in the Rheumatology Service of the ¨Hermanos Ameijeiras¨ Hospital in Havana, Cuba. In the period from September 2022 to September 2024. 55 patients were included
Results: The mean age was 58.8 ± 11.1, the female sex predominated 58.2% and white skin color 58.2%, the most observed associated disease was obesity with 30.9%, the most affected anatomical region was the shoulder 58.1% and the most prevalent lesion was tenosynovitis of the long head of the biceps 40%, the time of onset of symptoms was 9.7 months. The therapeutic response according to the Visual Analog Scale (VAS) and the Disabilities of the Arm, Shoulder and Hand (DASH) improved with follow-up time showing a significant association <0.001. Mild pain was the most frequent adverse event.
Conclusions: The most affected anatomical region was the shoulder, the lesion of tenosynovitis of the long head of the biceps predominated. The application of PRP showed improvement in pain and function.
Downloads
References
Referencias bibliográficas
1. Chellini F, Tani A, Zecchi-Orlandini S, Sassoli C. Influence of Platelet-Rich and Platelet-Poor Plasma on Endogenous Mechanisms of Skeletal Muscle Repair/Regeneration. International journal of molecular sciences. 2019;20(3). Epub 2019/02/16. doi: 10.3390/ijms20030683.
2. Dzakpasu FQS, Carver A, Brakenridge CJ, Cicuttini F, Urquhart DM, Owen N, et al. Musculoskeletal pain and sedentary behaviour in occupational and non-occupational settings: a systematic review with meta-analysis. The international journal of behavioral nutrition and physical activity. 2021;18(1):159. Epub 2021/12/14. doi: 10.1186/s12966-021-01191-y.
3. Filatova YS, Ilyin MV. [The use of sodium hyaluronate to treat upper limb disease: A review]. Terapevticheskii arkhiv. 2023;95(5):438-43. Epub 2024/01/02. doi: 10.26442/00403660.2023.05.202273.
4. Daliri M, Khosravi F, Shakeri MT, Ebrahimzadeh MH, Moradi A. Pairwise association of upper extremity musculoskeletal conditions: large population investigation from PERSIAN cohort study. Journal of orthopaedic surgery and research. 2023;18(1):626. Epub 2023/08/27. doi: 10.1186/s13018-023-04108-6.
5. De La Mata J. Platelet rich plasma. A new treatment tool for the rheumatologist? Reumatología Clínica (English Edition). 2013;9(3):166-71. English, Spanish. doi: 10.1016/j.reuma.2012.05.011.
6. Gupta S, Paliczak A, Delgado D. Evidence-based indications of platelet-rich plasma therapy. Expert review of hematology. 2021;14(1):97-108. Epub 2020/12/05. doi: 10.1080/17474086.2021.1860002.
7. Chen S-R, Shen Y-P, Ho T-Y, Li T-Y, Su Y-C, Chou Y-C, et al. One-year efficacy of platelet-rich plasma for moderate-to-severe carpal tunnel syndrome: a prospective, randomized, double-blind, controlled trial. 2021;102(5):951-8. doi: 10.1016/j.apmr.2020.12.025.
8. Unlu MC, Kivrak A, Kayaalp ME, Birsel O, Akgun I. Peritendinous injection of platelet-rich plasma to treat tendinopathy: A retrospective review. Acta orthopaedica et traumatologica turcica. 2017;51(6):482-7. Epub 2017/11/08. doi: 10.1016/j.aott.2017.10.003.
9. Wu YT, Ho TY, Chou YC, Ke MJ, Li TY, Huang GS, et al. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. Scientific reports. 2017;7(1):94. Epub 2017/03/10. doi: 10.1038/s41598-017-00224-6. PubMed PMID: 28273894;
10. Godah M, Chaaya M, Slim Z, Uthman I. Risk factors for incident shoulder soft tissue rheumatic disorders: a population-based case-control study in Lebanon. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2018;24(4):393-400. Epub 2018/07/05. doi: 10.26719/2018.24.4.393.
11. Almirón M, Barrios IJMCyS. Valoración funcional de pacientes con lesiones del miembro superior a través del cuestionario DASHe. 2018;2(3):136-44. doi: https://doi.org/10.52379/mcs.v2i3.66.
12. Clari M, Garzaro G, Di Maso M, Donato F, Godono A, Paleologo M, et al. Upper Limb Work-Related Musculoskeletal Disorders in Operating Room Nurses: A Multicenter Cross-Sectional Study. International journal of environmental research and public health. 2019/08/10 ed2019.
13. Sarwar S, Khalid S, Mahmood T, Jabeen H, Imran SJJoIM, College D. Frequency of neck and upper extremity musculoskeletal disorders in dentists. 2020;9(3):207-11. doi: https://doi.org/10.35787/jimdc.v9i3.404.
14. Zeng QY, Zang CH, Lin L, Chen SB, Li XF, Xiao ZY, et al. Epidemiologic study of soft tissue rheumatism in Shantou and Taiyuan, China. Chinese medical journal. 2010;123(15):2058-62. Epub 2010/09/08.
15. Nambiema A, Bertrais S, Bodin J, Fouquet N, Aublet-Cuvelier A, Evanoff B, et al. Proportion of upper extremity musculoskeletal disorders attributable to personal and occupational factors: results from the French Pays de la Loire study. BMC public health. 2020;20(1):456. Epub 2020/04/08. doi: 10.1186/s12889-020-08548-1.
16. Thu AC, Kwak SG, Shein WN, Htun M, Htwe TTH, Chang MC. Comparison of ultrasound-guided platelet-rich plasma injection and conventional physical therapy for management of adhesive capsulitis: a randomized trial. The Journal of international medical research. 2020;48(12):300060520976032. Epub 2020/12/10. doi: 10.1177/0300060520976032.
17. Linnanmäki L, Kanto K, Karjalainen T, Leppänen OV, Lehtinen J. Platelet-rich Plasma or Autologous Blood Do Not Reduce Pain or Improve Function in Patients with Lateral Epicondylitis: A Randomized Controlled Trial. Clinical orthopaedics and related research. 2020;478(8):1892-900. Epub 2020/08/01. doi: 10.1097/corr.0000000000001185.
18. Martin JI, Atilano L, Merino J, Gonzalez I, Iglesias G, Areizaga L, et al. Platelet-rich plasma versus lidocaine as tenotomy adjuvants in people with elbow epicondylopathy: a randomized controlled trial. Journal of orthopaedic surgery and research. 2019;14(1):109. Epub 2019/04/25. doi: 10.1186/s13018-019-1153-6.
19. Malahias MA, Nikolaou VS, Johnson EO, Kaseta MK, Kazas ST, Babis GC. Platelet-rich plasma ultrasound-guided injection in the treatment of carpal tunnel syndrome: A placebo-controlled clinical study. Journal of tissue engineering and regenerative medicine. 2018;12(3):e1480-e8. Epub 2017/09/06. doi: 10.1002/term.2566.
20. Martínez-Martínez A, Ruiz-Santiago F, García-Espinosa J. Platelet-rich plasma: myth or reality? Radiologia. 2018;60(6):465-75. Epub 2018/10/03. doi: 10.1016/j.rx.2018.08.006.
21. Landro ME, Martucci LC, Margulies M, Douglas Price AL, Caviglia HA. Platelet-Rich Plasma for Musculoskeletal Disorders: No Infection Reported in Daily Practice. 2022;9(2):e126321. Epub 2022-06-01. doi: 10.5812/jssc-126321.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Araceli Chico Capote, Miguel Hernán Estévez del Toro, Alejandro Santos Barbery, Rolando Dayan Puente Carmona
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
